Skip to main content

Schwartz Jeffrey Lawrence's Form 4 filing

Rapid Micro Biosystems, Inc.RPID · filed Jul 21, 2021

Accession no.
0000899243-21-029222
Filed
Jul 21, 2021, 4:40 PM ET
Trade date
Jul 19, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $2.00M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schwartz Jeffrey LawrenceCIK 0001702957Director, 10% Owner
Koppel AdamCIK 000157896510% Owner
Bain Capital Life Sciences Fund, L.P.CIK 000168796810% Owner
BCIP Life Sciences Associates, LPCIK 000170292110% Owner
Bain Capital Life Sciences Partners, LPCIK 000170303010% Owner
Bain Capital Life Sciences Investors, LLCCIK 000170303110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 19, 2021Class A Common StockCConversionAcquired+6,999,998–F1–6,999,998Indirect
Jul 19, 2021Class A Common StockCConversionAcquired+1,334,562–F1–8,334,560Indirect
Jul 19, 2021Class A Common StockPPurchaseAcquired+100,000$20.00+$2,000,0008,434,560Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 19, 2021Class A Common StockCConversionDisposed−6,999,998–F1–0Indirect
Jul 19, 2021Class A Common StockCConversionDisposed−1,334,562–F1–0Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each share of the Issuer's Series B1 Preferred Stock and Series C1 Preferred Stock automatically converted into 0.2 of a share of the Issuer's Class A Common Stock immediately prior to the closing of the Issuer's initial public offering.

Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)